SCHEMBL24008459

SCHEMBL24008459

FC(F)(F)c1ccnc(N2CCCCC2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.71
FFAR4 Q5NUL3 1/20 0.50
HRH4 Q9H3N8 1/20 0.50
MAPT P10636 2/20 0.49
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP2D6 P10635 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CCR6 P51684 1/20 0.47
AR P10275 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
NOS3 P29474 1/20 0.46
NOS2 P35228 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
TRPV1 Q8NER1 2/20 0.44
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
ITGB2 P05107 1/20 0.44
ICAM1 P05362 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18176129 0.98 ADRB1 (0.73) ADRB1FFAR4HRH4MAPTKDM4E
SCHEMBL30582925 0.89 ADRB1 (0.62) ADRB1FFAR4HRH4MAPTKDM4E
SCHEMBL30582877 0.89 ADRB1 (0.62) ADRB1FFAR4HRH4MAPTKDM4E
Tert-Butyl Formate SCHEMBL27852289 0.85 ADRB1 (0.54) ADRB1FFAR4HRH4MAPTKDM4E
SCHEMBL1998032 0.85 ADRB1 (0.69) ADRB1FFAR4MAPTKDM4EALDH1A1
SCHEMBL1901605 0.85 ADRB1 (0.69) ADRB1FFAR4MAPTKDM4EALDH1A1
SCHEMBL210342 0.83 ADRB1 (1.00) ADRB1FFAR4MAPTKDM4EALDH1A1
SCHEMBL30567166 0.83 ADRB1 (1.00) ADRB1FFAR4MAPTKDM4EALDH1A1
SCHEMBL24363082 0.83 ADRB1 (0.68) ADRB1FFAR4MAPTKDM4EALDH1A1
SCHEMBL12968838 0.83 ADRB1 (0.68) ADRB1FFAR4HRH4MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780861-B2 Phosphine reagents for azine fluoroalkylation COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2023-10-10 US disclosed
WO-2021224864-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2021-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780861-B2 Phosphine reagents for azine fluoroalkylation PTPN3, PHOSPHO1, SKIC3 ADRB1 4000/4885FFAR4 1055/4885HRH4 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.